Molecular targets for chemoprevention: Role in choosing and developing new agents

Cuzik, 2003, Overview of the main outcomes in breast-cancer prevention trials, Lancet, 361, 296, 10.1016/S0140-6736(03)12342-2 Thompson, 2003, The influence of finasteride on the development of prostate cancer, N Engl J Med, 349, 215, 10.1056/NEJMoa030660 Beta Carotene Cancer Prevention Study Group, 1994, The Alpha-Tocopheral. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers, N Engl J Med, 330, 1029, 10.1056/NEJM199404143301501 Sebolt-Leopold, 2004, Targeting the mitogen-activated protein kinase cascade to treat cancer, Nature Revs Cancer, 4, 937, 10.1038/nrc1503 Chen, 1998, Inhibition of the c-jun N-terminal kinase (JNK) signalling pathway by curcumin, Oncogene, 17, 173, 10.1038/sj.onc.1201941 Yu, 2004, The STATs of cancer – new molecular targets come of age, Nature Revs Cancer, 4, 97, 10.1038/nrc1275 Pikarsky, 2004, NF-úB functions as a tumour promoter in inflammation-associated cancer, Nature, 431, 461, 10.1038/nature02924 Diehl, 2002, Cycling to cancer with cyclin D1, Cancer Biol Ther, 3, 226, 10.4161/cbt.72 Bohmann, 1987, Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1, Science, 238, 1386, 10.1126/science.2825349 Dannenberg, 2003, Targeting cycloocygenase-2 in human neoplasia: rationale and promise, Cancer Cell, 4, 431, 10.1016/S1535-6108(03)00310-6